Literature DB >> 17150190

Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling.

Kento Tateishi1, Eishi Ashihara, Shoken Honsho, Naofumi Takehara, Tetsuya Nomura, Tomosaburo Takahashi, Tomomi Ueyama, Masaaki Yamagishi, Hitoshi Yaku, Hiroaki Matsubara, Hidemasa Oh.   

Abstract

Recent evidence suggested that human cardiac stem cells (hCSCs) may have the clinical application for cardiac repair; however, their characteristics and the regulatory mechanisms of their growth have not been fully investigated. Here, we show the novel property of hCSCs with respect to their origin and tissue distribution in human heart, and demonstrate the signaling pathway that regulates their growth and survival. Telomerase-active hCSCs were predominantly present in the right atrium and outflow tract of the heart (infant > adult) and had a mesenchymal cell-like phenotype. These hCSCs expressed the embryonic stem cell markers and differentiated into cardiomyocytes to support cardiac function when transplanted them into ischemic myocardium. Inhibition of Akt pathway impaired the hCSC proliferation and induced apoptosis, whereas inhibition of glycogen synthase kinase-3 (GSK-3) enhanced their growth and survival. We conclude that hCSCs exhibit mesenchymal features and that Akt/GSK-3beta may be crucial modulators for hCSC maintenance in human heart.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150190     DOI: 10.1016/j.bbrc.2006.11.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study.

Authors:  Remco Koninckx; Annick Daniëls; Severina Windmolders; Françoise Carlotti; Urbain Mees; Paul Steels; Jean-Luc Rummens; Marc Hendrikx; Karen Hensen
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

2.  Boot camp for mesenchymal stem cells.

Authors:  Eduardo Marbán; Konstantinos Malliaras
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

Review 3.  Stem cell death and survival in heart regeneration and repair.

Authors:  Eltyeb Abdelwahid; Audrone Kalvelyte; Aurimas Stulpinas; Katherine Athayde Teixeira de Carvalho; Luiz Cesar Guarita-Souza; Gabor Foldes
Journal:  Apoptosis       Date:  2016-03       Impact factor: 4.677

Review 4.  "AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation.

Authors:  Mark Sussman
Journal:  Trends Cardiovasc Med       Date:  2007-10       Impact factor: 6.677

Review 5.  Genetic enhancement of stem cell engraftment, survival, and efficacy.

Authors:  Marc S Penn; Abeel A Mangi
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

Review 6.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

7.  Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.

Authors:  Victoria Florea; Sonia S Majid; Rosemeire M Kanashiro-Takeuchi; Ren-Zhi Cai; Norman L Block; Andrew V Schally; Joshua M Hare; Claudia O Rodrigues
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 8.  Stem cell therapies in patients with single ventricle physiology.

Authors:  Suguru Tarui; Shunji Sano; Hidemasa Oh
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Apr-Jun

Review 9.  Targeting GSK-3 family members in the heart: a very sharp double-edged sword.

Authors:  Hui Cheng; James Woodgett; Mia Maamari; Thomas Force
Journal:  J Mol Cell Cardiol       Date:  2010-12-13       Impact factor: 5.000

10.  Allogeneic cell therapy: a new paradigm in therapeutics.

Authors:  Vasileios Karantalis; Ivonne Hernandez Schulman; Wayne Balkan; Joshua M Hare
Journal:  Circ Res       Date:  2015-01-02       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.